Work

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

Year: 2011

Type: article

Source: Leukemia

DOI: 10.1038/leu.2011.360

Authors: E Weisberg, A K Azab, P W Manley, A L Kung, A L Christie, R Bronson, I M Ghobrial, J D Griffin

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Novartis (Switzerland), Boston Children's Hospital

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1570399396, G2852253759, CXCR4 regulation of tumor progression in Multiple Myeloma

OpenAlex ID: W1978466041

FWCI: 8.297

Cites: 43

Cited by: 129

Related to: 10